Citigroup Maintains Buy on Privia Health Gr, Lowers Price Target to $32

Privia Health Group, Inc. +1.38% Pre

Privia Health Group, Inc.

PRVA

23.44

23.44

+1.38%

0.00% Pre
Citigroup analyst Daniel Grosslight maintains Privia Health Gr (NASDAQ: PRVA) with a Buy and lowers the price target from $34 to $32.